The composition of Fimea’s patient advisory board for the term 2020–2021 has been confirmed

Fimea’s management team has confirmed the composition of the patient advisory board to comprise 15 patient and disability organisations and their representatives.

A total of 18 applications to participate in the operations of the patient advisory board were received by the deadline. When the organisations were selected, special attention was paid on the diversity of the composition: the members represent organisations of different size, and organisations representing both rare and chronic diseases are included. The composition of the advisory board has been published on separate sub-pages opened on Fimea’s website.

The operations of the patient advisory board can be followed from the website and by subscribing to the newsletter

The patient advisory board will convene for the first time in March 2020. In the future, the advisory board will convene twice a year. The meeting programmes and materials will be updated to the Fimea website to make them available to all. Additionally, Fimea will publish a newsletter for the advisory board that can be subscribed to on the website in the spring of 2020.

Read more:

The patient advisory board and its composition for the term 2020–2021

The action plan of Fimea’s patient advisory board for the term 2020-2021 (pdf, in Finnish)